Lataa...
Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?
Pancreatic ductal adenocarcinoma (PDAC) constitutes one of the most aggressive malignancies with a 5-year survival rate of <7%. Due to growing incidence, late diagnosis and insufficient treatment options, PDAC is predicted to soon become one of the leading causes of cancer-related death. Although...
Tallennettuna:
| Julkaisussa: | Gut |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BMJ Publishing Group
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5256386/ https://ncbi.nlm.nih.gov/pubmed/27811314 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gutjnl-2016-312539 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|